Page last updated: 2024-11-05

crimidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Crimidine is a heterocyclic compound that is structurally similar to pyridine. It is characterized by a six-membered ring containing three nitrogen atoms, and it is known for its ability to form stable complexes with metal ions, particularly transition metals. It is of interest for its potential applications in various fields, such as coordination chemistry, catalysis, and medicine. Crimidine synthesis can be achieved through a multi-step process involving various reagents, like carbon disulfide and hydrazine. Crimidine derivatives have been reported to exhibit diverse biological activities, including antimicrobial, anticancer, and anti-inflammatory effects. The compound has been studied due to its potential therapeutic benefits and its unique chemical properties that allow for the development of new materials and catalysts.'

crimidine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10813
CHEMBL ID1607733
CHEBI ID82258
SCHEMBL ID432253
MeSH IDM0045703

Synonyms (68)

Synonym
4-pyrimidinamine, 2-chloro-n,n,6-trimethyl-
w-491
2-chloro-4-dimethylamino-6-methylpyrimidine
2-chloro-4-methyl-6-dimethylaminopyrimidine
crimidin [german]
2-chloro-n,n,6-trimethylpyrimidin-4-ylamine
caswell no. 188
2-chlor-4-dimethylamino-6-methylpyrimidin [german]
2-cloro-4-dimetilamino-6-metil-pirimidina [italian]
crimidina [italian]
crimidine [iso:bsi]
2-chloro-n,n-6-trimethyl-4-pyrimidinamine
brn 0127995
2-chloro-4-dimethylamino-6-methyl-pyrimidine
2-chloor-4-dimethylamino-6-methyl-pyrimidine [dutch]
epa pesticide chemical code 288200
einecs 208-622-6
ai3-61801
hsdb 2812
nsc 2017
2-chlor-4-dimethylamino-6-methylpyrimidin
4-25-00-02184 (beilstein handbook reference)
unii-w34r2923t3
w34r2923t3 ,
EN300-27754
BB 0261463
nsc2017
w 491
535-89-7
2-chloor-4-dimethylamino-6-methyl-pyrimidine
2-cloro-4-dimetilamino-6-metil-pirimidina
2-chloro-4-(dimethylamino)-6-methylpyrimidine
crimidin
crimidina
nsc-2017
pyrimidine, 2-chloro-4-(dimethylamino)-6-methyl-
castrix
2-chloro-4-(dimethylamino)-6-methyl-pyrimidine
2-chloro-n,6-trimethyl-4-pyrimidinamine
crimidine
wln: t6n cnj bg dn1&1 f1
4-pyrimidinamine,n,6-trimethyl-
2-chloro-4-methyl-6-(dimethylamino)pyrimidine
NCGC00166162-01
2-chloro-n,n,6-trimethylpyrimidin-4-amine
STK377491
(2-chloro-6-methyl-pyrimidin-4-yl)-dimethyl-amine
C19138
(2-chloro-6-methylpyrimidin-4-yl)dimethylamine
AM804012
AKOS005177522
SCHEMBL432253
2-chloro-4-dimethylamino-6-methyl pyrimidine
crimidine [mi]
crimidine [iso]
crimidine [hsdb]
2-chloro-n,n,6-trimethyl-4-pyrimidinamine
CHEBI:82258 ,
CHEMBL1607733
DTXSID0041800
F1905-0504
crimidine, pestanal(r), analytical standard
crimidine 10 microg/ml in acetonitrile
AS-54836
mfcd00055517
Q2645488
W10442
A853931

Research Excerpts

Treatment

ExcerptReferenceRelevance
"The treatment of crimidine poisoning is time consuming and requires intensive care facilities."( Crimidine (2-chloro-4-(dimethylamino)-6-methylpyrimidine) poisoning in a dog due to ingestion of the rodenticide Castrix.
de Vries, HW; Lumeij, JT; Schotman, AJ, 1983
)
2.04

Dosage Studied

ExcerptRelevanceReference
" The potential adverse effects of excessive pyridoxine dosage will also be summarized."( Pyridoxine in clinical toxicology: a review.
Gris, M; Lheureux, P; Penaloza, A, 2005
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
pyrimidinesAny compound having a pyrimidine as part of its structure.
organohalogen compoundA compound containing at least one carbon-halogen bond (where X is a halogen atom).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Ferritin light chainEquus caballus (horse)Potency5.62345.623417.292931.6228AID485281
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1433960Inhibition of phosphatidyl serine liposome-stimulated sheep brain dynamin 1 GTPase activity assessed as reduction orthophosphate release up to 300 uM using GTP as substrate after 30 mins by malachite green reagent based colorimetric assay relative to cont2017Journal of medicinal chemistry, 01-12, Volume: 60, Issue:1
Pyrimidine-Based Inhibitors of Dynamin I GTPase Activity: Competitive Inhibition at the Pleckstrin Homology Domain.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (75.00)18.7374
1990's0 (0.00)18.2507
2000's2 (16.67)29.6817
2010's1 (8.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.70 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.69%)6.00%
Case Studies2 (15.38%)4.05%
Observational0 (0.00%)0.25%
Other10 (76.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]